Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Viva Biotech's Portfolio Company DTx Pharma Reached the Acquisition Agreement with Novartis 2023-07-18 15:00
Join Taipei City's Thriving Health Industry: Registration for "Win A Greater Health" Pitch Contest Starts Now! 2023-07-18 11:35
TradeWinds Partners with TMBIA to Showcase Taiwan Pavilion at VIETNAM MEDI-PHARM EXPO 2023-07-18 09:00
SK Biopharmaceuticals Makes Big Bets to be 'Big Biotech' 2023-07-18 09:00
Antengene Announces First Patient Dosed in the Nivolumab Combination Portion of the Clinical Study Evaluating the ERK1/2 Inhibitor ATG-017 in Patients with Advanced Solid Tumors in the United States 2023-07-18 08:30
BIORCHESTRA Wins Grand Prize in 2023 Merck Advance Biotech Grant Program 2023-07-17 21:28
GeneQuantum and InxMed have reached a technology licensing collaboration, providing strong support for innovative ADC drug research and development 2023-07-17 17:00
Precedential US Federal Court Decision Hands SNIPR Biome a win in patent appeal over Rockefeller University for CRISPR-Cas microbial gene editing 2023-07-17 15:09
Antengene Announces XPOVIO® Regulatory Approval in Hong Kong for the Treatment of Relapsed and/or Refractory Multiple Myeloma 2023-07-17 08:30
MGI Empowers Life Sciences Industry with Revolutionary What If Campaign at XXIIIrd International Congress of Genetics 2023-07-17 07:00
Nona Biosciences Announces Business Update of Collaboration on Antibody Drug Conjugate (ADC) with DualityBio 2023-07-14 08:29
Menarini Silicon Biosystems announces the launch of its new CELLSEARCH® CTC test with the DLL3 biomarker for small cell lung cancer 2023-07-13 20:00
Harbour BioMed Announces 2023 Interim Results Positive Profit Alert with the Enhancement of Value Driven by Innovation 2023-07-13 18:11
Sirnaomics to Present Latest Developments on Two Proprietary Delivery Platforms at Upcoming Industry Conferences 2023-07-12 20:45
Race executes agreement with Ardena for GMP manufacturing of RC220 2023-07-12 19:30
Medicilon Appoints Dr. Liu Jian as President of Drug Discovery Division 2023-07-12 18:46
Best Presentation Award at EASL Congress 2023: First-in-class Bispecific Antibodies Anti-HBs×CD3 and Anti-HBs×CD28 Showed Strong Preclinical Efficacy in HBV Cure 2023-07-12 18:13
Biosyngen's First-in-class Cell Therapy BRG01 Receives FDA Fast Track Designation 2023-07-12 13:38
Creating the China-Singapore Translational Medicine Center - Biosyngen's pursuit to be a leading player in the CGT industry globally hits new milestone. 2023-07-12 10:32
Sciwind Biosciences Announces Publication of Discovery, Preclinical, and Phase 1 Clinical Trial Results of Ecnoglutide (XW003) in Molecular Metabolism 2023-07-12 10:00
1 93 94 95 96 97 452